J1561 HCPCS code: Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg

J1561 is the HCPCS Level II code for injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg. In 2024 Medicare paid an average of $38.11 per service for J1561 across 3,493,569 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 360 per day on DME suppliers. Medicare volume rose 26% from 2022 to 2024 (2,782,041 to 3,493,569 services). In 2024, 264 suppliers billed Medicare for J1561 (purchases), serving 1,082 beneficiaries; Florida, Alabama, Texas accounted for 27% of services.

Code details

FieldValue
SectionJ codes — Drugs administered other than oral method
Coverage codeD — Special coverage instructions apply
Pricing indicator51 — Drug or biological (priced per ASP/average sales price rules)
BETOS categoryO1E — Other drugs
Added2008-01-01
Last action effective2013-01-01

Who bills J1561 (2024)

MeasureValue
Suppliers billing rentals—
Suppliers billing purchases264
Referring clinicians805
Medicare beneficiaries1,082
States with claims47
Share of services in top 3 states (Florida, Alabama, Texas)27%
YearSuppliersBeneficiaries
20222441,033
2023227973
20242641,082

Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.

Medicare utilization for J1561, 2022–2024

YearServicesBeneficiariesAvg. allowedAvg. paid
20222,782,0413,658$43.40$34.61
20232,801,3793,521$47.39$37.73
20243,493,5694,107$47.87$38.11

States with the most J1561 services (2024)

StateServicesAvg. paid
Texas1,069,658$38.25
New York378,147$37.62
California354,684$38.38
Florida130,862$37.47
South Carolina119,946$38.06

NCCI unit limits (MUE)

Claim typeMax units per dayRationale
DME suppliers360Clinical: Data
outpatient hospital claims360Clinical: Data
practitioner claims360Clinical: Data

Medicare policy articles for this code

Covered diagnoses (1,880 ICD-10-CM codes)

The diagnoses most often listed as covered in the policy articles above:

ICD-10-CMDiagnosisArticles listing it
D69.3Immune thrombocytopenic purpura8
D80.0Hereditary hypogammaglobulinemia8
D80.2Selective deficiency of immunoglobulin A [IgA]8
D80.3Selective deficiency of immunoglobulin G [IgG] subclasses8
D80.4Selective deficiency of immunoglobulin M [IgM]8
D80.5Immunodeficiency with increased immunoglobulin M [IgM]8
D80.6Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia8
D80.7Transient hypogammaglobulinemia of infancy8
D81.0Severe combined immunodeficiency [SCID] with reticular dysgenesis8
D81.1Severe combined immunodeficiency [SCID] with low T- and B-cell numbers8

Showing 10 of 1,880. The full list, non-covered diagnoses and CSV export are in Caduvo.

What changed for J1561

Frequently asked questions

What is HCPCS code J1561?

J1561 is the HCPCS Level II code for injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg. Short descriptor: "Gamunex-c/gammaked".

How much does Medicare pay for J1561?

In 2024, the average Medicare payment was $38.11 per service (average allowed $47.87).

Does Medicare cover J1561?

Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.

Which diagnoses support coverage for J1561?

Medicare policy articles that cite J1561 list 1,880 covered ICD-10-CM diagnosis codes across 9 articles. The most cited include D69.3 (Immune thrombocytopenic purpura), D80.0 (Hereditary hypogammaglobulinemia), D80.2 (Selective deficiency of immunoglobulin A [IgA]). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.

How many units of J1561 can be billed per day?

360 on DME suppliers; 360 on outpatient hospital claims; 360 on practitioner claims (NCCI medically unlikely edits).

Related J15 codes

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.

All J codes · HCPCS lookup